| PH (N = 12) | HFrEF (N = 10) | Normal (N = 10) | p-value |
---|---|---|---|---|
Age (years [IQR]) | 64.5 (47.5–70.5) | 60.0 (53.0–65.0) | 24.4 (21.7–26.3 | <0.001 |
Gender (% female) | 8 (66.7) | 1 (10.0) | 8 (80.0) | 0.004 |
BMI (kg/m2 [IQR]) | 25.4 (23.0–29.3) | 29.2 (26.0–32.7) | 24.1 (21.2–26.3) | 0.47 |
Ischemic HD (%) | 1 (8.3) | 8 (80.0) | 0 (0.0) | <0.0001 |
Congenital HD (%) | 1a (8.3) | 1 (10.0) | 0 (0.0) | 1.0 |
DM (%) | 2 (16.7) | 3 (30.0) | 0 (0.0) | 0.23 |
OSA (%) | 3 (25.0) | 2 (20.0) | 0 (0.0) | 0.33 |
HIV (%) | 2 (16.7) | 0 (0.0) | 0 (0.0) | 0.31 |
CTEPH (%) | 2 (16.7) | 0 (0.0) | 0 (0.0) | 0.31 |
Medication-ERA | 6 (50.0) | 0 (0.0) | 0 (0.0) | 0.002 |
Medication-sildenafil | 7 (58.3) | 0 (0.0) | 0 (0.0) | 0.0003 |
Medication-PA | 2 (16.7) | 0 (0.0) | 0 (0.0) | 0.31 |